GRAIL, Inc. $GRAL Holdings Decreased by Deutsche Bank AG

Key Points

• Deutsche Bank AG has reduced its holdings in GRAIL, Inc. by 68.2%, ending the first quarter with approximately 0.05% ownership, valued at $456,000.
• Canaccord Genuity Group upgraded GRAIL's target price from $32.00 to $43.00 and rated it "buy," while the average rating is currently a "Hold" with a consensus price target of $31.50.
• Insider selling has occurred recently, including major shareholder Chun R. Ding who sold 339,800 shares for about $16.83 million, leading to a decrease in his ownership position by 9.32%.

Deutsche Bank AG cut its position in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 68.2% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 17,846 shares of the company's stock after selling 38,216 shares during the quarter. Deutsche Bank AG owned 0.05% of GRAIL worth $456,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Wells Fargo & Company MN acquired a new position in shares of GRAIL during the 4th quarter valued at $90,000. GAMMA Investing LLC increased its position in shares of GRAIL by 4,102.5% during the 1st quarter. GAMMA Investing LLC now owns 25,131 shares of the company's stock valued at $642,000 after purchasing an additional 24,533 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new position in shares of GRAIL in the 1st quarter worth $719,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of GRAIL during the fourth quarter worth $1,201,000. Finally, Stifel Financial Corp acquired a new stake in shares of GRAIL during the fourth quarter worth $625,000.

Insider Activity

In other news, major shareholder Chun R. Ding sold 339,800 shares of GRAIL stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total transaction of $16,830,294.00. Following the transaction, the insider owned 3,305,055 shares in the company, valued at approximately $163,699,374.15. The trade was a 9.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 9,692 shares of GRAIL stock in a transaction on Monday, June 30th. The shares were sold at an average price of $52.00, for a total value of $503,984.00. Following the transaction, the president owned 492,076 shares in the company, valued at $25,587,952. This represents a 1.93% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 361,694 shares of company stock worth $17,780,266. 1.85% of the stock is owned by corporate insiders.

GRAIL Trading Down 3.9%

Shares of GRAIL stock traded down $1.32 on Monday, reaching $32.79. 693,949 shares of the company were exchanged, compared to its average volume of 774,663. The stock has a fifty day moving average price of $38.01 and a 200-day moving average price of $36.24. The firm has a market capitalization of $1.18 billion, a price-to-earnings ratio of -2.50 and a beta of 3.20. GRAIL, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%.The company had revenue of $35.54 million for the quarter, compared to analyst estimates of $37.57 million. On average, equities analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group boosted their target price on GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $31.50.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.